Skip to main content
Top
Published in: BMC Pediatrics 1/2008

Open Access 01-12-2008 | Research article

Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness

Authors: Yiu-fai Cheung, Karmin O, Connie WH Woo, Stephanie Armstrong, Yaw L Siow, Pak-cheong Chow, Eddie WY Cheung

Published in: BMC Pediatrics | Issue 1/2008

Login to get access

Abstract

Background

Persistent arterial dysfunction in patients with a history of Kawasaki disease (KD) and an integral role of oxidative stress in the development of cardiovascular disease are increasingly recognized. We sought to test the hypothesis that oxidative stress is increased in KD patients and related to carotid atherosclerotic changes and stiffness.

Methods

We compared the serum levels of oxidative stress biomarkers, carotid intima-media thickness (IMT), and carotid stiffness index among KD patients with coronary aneurysms (n = 32), those without coronary complications (n = 19), and controls (n = 32).

Results

Compared with controls, patients with coronary aneurysms had significantly higher serum levels of malonaldehyde (2.62 ± 0.12 μM vs 2.22 ± 0.07 μM, p = 0.014) and hydroperoxides (26.50 ± 1.13 μM vs 22.50 ± 0.62 μM, p = 0.008). A linear trend of the magnitude of oxidative stress in relation to inflammatory damage was observed for malonaldehyde (p = 0.018) and hydroperoxides (p = 0.014) levels. Serum malonaldehyde and hydroperoxide levels correlated positively with carotid IMT (p < 0.001 and p = 0.034, respectively) and stiffness index (p = 0.001 and p = 0.021, respectively). Multiple linear regression analysis identified serum malonaldehyde level as a significant determinant of carotid IMT (β = 0.31, p = 0.006) and stiffness (β = 0.27, p = 0.008).

Conclusion

Our findings suggest oxidative stress is increased in KD patients with coronary aneurysms and is associated with carotid intima-media thickening and stiffening.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 patients. Jpn J Allergy. 1967, 16: 178-222. Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 patients. Jpn J Allergy. 1967, 16: 178-222.
2.
go back to reference Tauber KA, Rowley AH, Shulman ST: Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994, 13: 704-708.CrossRef Tauber KA, Rowley AH, Shulman ST: Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994, 13: 704-708.CrossRef
3.
go back to reference Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N: Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Ped. 1992, 121: 684-688. 10.1016/S0022-3476(05)81893-1.CrossRef Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N: Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Ped. 1992, 121: 684-688. 10.1016/S0022-3476(05)81893-1.CrossRef
4.
go back to reference Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H: Coronary endothelial dysfunction after Kawasaki disease: Evaluation by intracoronary injection of Acetylcholine. J Am Coll Cardiol. 1998, 31: 1074-1080. 10.1016/S0735-1097(98)00033-3.CrossRefPubMed Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H: Coronary endothelial dysfunction after Kawasaki disease: Evaluation by intracoronary injection of Acetylcholine. J Am Coll Cardiol. 1998, 31: 1074-1080. 10.1016/S0735-1097(98)00033-3.CrossRefPubMed
5.
go back to reference Iemura M, Ishii M, Sugimura T, Akagi T, Kato H: Long term consequences of regressed coronary aneurysms after Kawasaki disease with vascular wall morphology and function. Heart. 2000, 83: 307-311. 10.1136/heart.83.3.307.CrossRefPubMedPubMedCentral Iemura M, Ishii M, Sugimura T, Akagi T, Kato H: Long term consequences of regressed coronary aneurysms after Kawasaki disease with vascular wall morphology and function. Heart. 2000, 83: 307-311. 10.1136/heart.83.3.307.CrossRefPubMedPubMedCentral
6.
go back to reference Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE: Endothelial dysfunction late after Kawasaki disease. Circulation. 1996, 94: 2103-2106.CrossRefPubMed Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE: Endothelial dysfunction late after Kawasaki disease. Circulation. 1996, 94: 2103-2106.CrossRefPubMed
7.
go back to reference Noto N, Okada T, Yamasuge M, Taniquchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K: Noninvasive assessment of the early progression of atherosclerosis in adolescents in Kawasaki disease and coronary artery lesions. Pediatrics. 2001, 107: 1095-1099. 10.1542/peds.107.5.1095.CrossRefPubMed Noto N, Okada T, Yamasuge M, Taniquchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K: Noninvasive assessment of the early progression of atherosclerosis in adolescents in Kawasaki disease and coronary artery lesions. Pediatrics. 2001, 107: 1095-1099. 10.1542/peds.107.5.1095.CrossRefPubMed
8.
go back to reference Cheung YF, Yung TC, Tam SCF, Ho MHK, Chau AKT: Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis. J Am Coll Cardiol. 2004, 43: 120-124. 10.1016/j.jacc.2003.08.030.CrossRefPubMed Cheung YF, Yung TC, Tam SCF, Ho MHK, Chau AKT: Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis. J Am Coll Cardiol. 2004, 43: 120-124. 10.1016/j.jacc.2003.08.030.CrossRefPubMed
9.
go back to reference Senzaki H, Chen CH, Ishido H, Masutani S, Matsunaga T, Taketazu M, Yokote Y, Kobayashi T, Sasaki N, Kyo S: Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005, 111: 2119-2125. 10.1161/01.CIR.0000162483.51132.25.CrossRefPubMed Senzaki H, Chen CH, Ishido H, Masutani S, Matsunaga T, Taketazu M, Yokote Y, Kobayashi T, Sasaki N, Kyo S: Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005, 111: 2119-2125. 10.1161/01.CIR.0000162483.51132.25.CrossRefPubMed
10.
go back to reference Cheung YF, Wong SJ, Ho MH: Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Childhood. 2007, 92: 43-47. 10.1136/adc.2006.096628.CrossRef Cheung YF, Wong SJ, Ho MH: Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Childhood. 2007, 92: 43-47. 10.1136/adc.2006.096628.CrossRef
11.
go back to reference Slyper AH: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab. 2004, 89: 3089-3095. 10.1210/jc.2003-030644.CrossRefPubMed Slyper AH: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab. 2004, 89: 3089-3095. 10.1210/jc.2003-030644.CrossRefPubMed
12.
go back to reference Rueckschloss U, Duerrschmidt N, Morawietz H: NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid Redox Signal. 2003, 5: 171-180. 10.1089/152308603764816532.CrossRefPubMed Rueckschloss U, Duerrschmidt N, Morawietz H: NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid Redox Signal. 2003, 5: 171-180. 10.1089/152308603764816532.CrossRefPubMed
13.
go back to reference Rueckschloss U, Quinn MT, Holtz J, Morawietz H: Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002, 22: 1845-1851. 10.1161/01.ATV.0000035392.38687.65.CrossRefPubMed Rueckschloss U, Quinn MT, Holtz J, Morawietz H: Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002, 22: 1845-1851. 10.1161/01.ATV.0000035392.38687.65.CrossRefPubMed
14.
go back to reference Madamanchik N, Vendrov A, Runge M: Oxidative stress and vascular disease. Arterioscler Thomb Biol. 2005, 25: 29-38. Madamanchik N, Vendrov A, Runge M: Oxidative stress and vascular disease. Arterioscler Thomb Biol. 2005, 25: 29-38.
15.
go back to reference Stocker R, Keaney JF: Role of oxidized modifications in atherosclerosis. Physiol Rev. 2001, 84: 1381-1478. 10.1152/physrev.00047.2003.CrossRef Stocker R, Keaney JF: Role of oxidized modifications in atherosclerosis. Physiol Rev. 2001, 84: 1381-1478. 10.1152/physrev.00047.2003.CrossRef
16.
go back to reference Liao J, Shin W, Lee W, Clark S: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995, 270: 319-324. 10.1074/jbc.270.1.319.CrossRefPubMed Liao J, Shin W, Lee W, Clark S: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995, 270: 319-324. 10.1074/jbc.270.1.319.CrossRefPubMed
17.
go back to reference Jialal I: Evolving lipoprotein risk factors: lipoprotein (a) and oxidized low-density lipoprotein. Clin Chem. 1998, 44: 1827-1832.PubMed Jialal I: Evolving lipoprotein risk factors: lipoprotein (a) and oxidized low-density lipoprotein. Clin Chem. 1998, 44: 1827-1832.PubMed
18.
go back to reference Cracowski JL, Durand T, Bessard G: Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002, 23: 360-366. 10.1016/S0165-6147(02)02053-9.CrossRefPubMed Cracowski JL, Durand T, Bessard G: Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002, 23: 360-366. 10.1016/S0165-6147(02)02053-9.CrossRefPubMed
19.
go back to reference Practico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, Fitzgerald GA: Localization of distinct F2-isoprostances in human atherosclerotic lesions. J Clin Invest. 1997, 100: 2028-2034. 10.1172/JCI119735.CrossRef Practico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, Fitzgerald GA: Localization of distinct F2-isoprostances in human atherosclerotic lesions. J Clin Invest. 1997, 100: 2028-2034. 10.1172/JCI119735.CrossRef
20.
go back to reference Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA: Vitamin E suppresses iso-prostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med. 1998, 4: 1189-1192. 10.1038/2685.CrossRefPubMed Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA: Vitamin E suppresses iso-prostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med. 1998, 4: 1189-1192. 10.1038/2685.CrossRefPubMed
21.
go back to reference Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association: Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004, 115: 1708-1733. 10.1542/peds.2004-2182.CrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association: Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004, 115: 1708-1733. 10.1542/peds.2004-2182.CrossRef
22.
go back to reference Research Committee on Kawasaki Disease: Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. 1984, Tokyo, Japan: Ministry of Health and Welfare Research Committee on Kawasaki Disease: Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. 1984, Tokyo, Japan: Ministry of Health and Welfare
23.
go back to reference Hirai T, Sasayama S, Kawasaki T, Yagi S: Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989, 80: 78-86.CrossRefPubMed Hirai T, Sasayama S, Kawasaki T, Yagi S: Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation. 1989, 80: 78-86.CrossRefPubMed
24.
go back to reference Yagi K: A simple fluorometric assay for lipoperoxide on blood plasma. Biochem Med. 1976, 15: 212-216. 10.1016/0006-2944(76)90049-1.CrossRefPubMed Yagi K: A simple fluorometric assay for lipoperoxide on blood plasma. Biochem Med. 1976, 15: 212-216. 10.1016/0006-2944(76)90049-1.CrossRefPubMed
25.
go back to reference Sung FL, Zhu TY, Au Yeung KK, Siow YL, O K: Enhanced MCP-1 expression during ischemia reperfusion injury is mediated by oxidative stress and NF-kappa B. Kidney Int. 2002, 62: 1160-1170. 10.1111/j.1523-1755.2002.kid577.x.CrossRefPubMed Sung FL, Zhu TY, Au Yeung KK, Siow YL, O K: Enhanced MCP-1 expression during ischemia reperfusion injury is mediated by oxidative stress and NF-kappa B. Kidney Int. 2002, 62: 1160-1170. 10.1111/j.1523-1755.2002.kid577.x.CrossRefPubMed
26.
go back to reference Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylophosphine. Anal Biochem. 1994, 220: 403-409. 10.1006/abio.1994.1357.CrossRefPubMed Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylophosphine. Anal Biochem. 1994, 220: 403-409. 10.1006/abio.1994.1357.CrossRefPubMed
27.
go back to reference Hermes-Lima M, Willmore WG, Storey KB: Quantification of lipid peroxidation in tissue extracts based on Fe(III) xylenol orange complex formation. Free Radic Biol Med. 1995, 19: 271-280. 10.1016/0891-5849(95)00020-X.CrossRefPubMed Hermes-Lima M, Willmore WG, Storey KB: Quantification of lipid peroxidation in tissue extracts based on Fe(III) xylenol orange complex formation. Free Radic Biol Med. 1995, 19: 271-280. 10.1016/0891-5849(95)00020-X.CrossRefPubMed
28.
go back to reference Deng Y, Li T, Xiang H, Chang Q, Li C: Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J. 2003, 22: 34-39. 10.1097/00006454-200301000-00011.CrossRefPubMed Deng Y, Li T, Xiang H, Chang Q, Li C: Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J. 2003, 22: 34-39. 10.1097/00006454-200301000-00011.CrossRefPubMed
29.
go back to reference Frei B, England L, Ames MN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989, 86: 6377-6381. 10.1073/pnas.86.16.6377.CrossRefPubMedPubMedCentral Frei B, England L, Ames MN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989, 86: 6377-6381. 10.1073/pnas.86.16.6377.CrossRefPubMedPubMedCentral
30.
go back to reference Wedgwood S, Dettman RW, Black SM: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 2001, 281: 1058-1067. Wedgwood S, Dettman RW, Black SM: ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 2001, 281: 1058-1067.
31.
go back to reference Ogawa S, Zhang J, Yuge K, Watanabe M, Fukazawa R, Kamisago M, Seki T, Hirayama T: Increased plasma endothelin-1 concentration in Kawasaki disease. J Cardiovasc Pharmacol. 1993, 22: S364-366.CrossRefPubMed Ogawa S, Zhang J, Yuge K, Watanabe M, Fukazawa R, Kamisago M, Seki T, Hirayama T: Increased plasma endothelin-1 concentration in Kawasaki disease. J Cardiovasc Pharmacol. 1993, 22: S364-366.CrossRefPubMed
32.
go back to reference Mitani Y: Coronary endothelial dysfunction after Kawasaki disease. J Am Coll Cardiol. 2000, 35: 821-822. 10.1016/S0735-1097(99)00622-1.CrossRefPubMed Mitani Y: Coronary endothelial dysfunction after Kawasaki disease. J Am Coll Cardiol. 2000, 35: 821-822. 10.1016/S0735-1097(99)00622-1.CrossRefPubMed
33.
go back to reference Cai H, DG Harrison: Endothelial dysfunction in cardiovascular disease. The role of oxidant stress. Circ Res. 2000, 87: 840-844.CrossRefPubMed Cai H, DG Harrison: Endothelial dysfunction in cardiovascular disease. The role of oxidant stress. Circ Res. 2000, 87: 840-844.CrossRefPubMed
34.
go back to reference Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996, 93: 1107-1113.CrossRefPubMed Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996, 93: 1107-1113.CrossRefPubMed
35.
go back to reference Ting HH, Timmimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996, 97: 22-28. 10.1172/JCI118394.CrossRefPubMedPubMedCentral Ting HH, Timmimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996, 97: 22-28. 10.1172/JCI118394.CrossRefPubMedPubMedCentral
36.
go back to reference Solzbach U, Hornig B, Jeserich M, Just H: Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 1997, 96: 1513-1519.CrossRefPubMed Solzbach U, Hornig B, Jeserich M, Just H: Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 1997, 96: 1513-1519.CrossRefPubMed
37.
go back to reference Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, Pulges A, Zilmer M: Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens. 2006, 19: 902-908. 10.1016/j.amjhyper.2006.02.003.CrossRefPubMed Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, Pulges A, Zilmer M: Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens. 2006, 19: 902-908. 10.1016/j.amjhyper.2006.02.003.CrossRefPubMed
38.
go back to reference Morrow JD: Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol. 2005, 25: 279-286. 10.1161/01.ATV.0000152605.64964.c0.CrossRefPubMed Morrow JD: Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol. 2005, 25: 279-286. 10.1161/01.ATV.0000152605.64964.c0.CrossRefPubMed
39.
go back to reference Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996, 98: 2572-2579. 10.1172/JCI119076.CrossRefPubMedPubMedCentral Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996, 98: 2572-2579. 10.1172/JCI119076.CrossRefPubMedPubMedCentral
40.
go back to reference Peng X, Haldar S, Deshpande S, Irani K, Kass DA: Wall stiffness suppresses Ake/e NOS and cytoprotection in pulse-perfused endothelium. Hypertension. 2003, 41: 378-381. 10.1161/01.HYP.0000049624.99844.3D.CrossRefPubMed Peng X, Haldar S, Deshpande S, Irani K, Kass DA: Wall stiffness suppresses Ake/e NOS and cytoprotection in pulse-perfused endothelium. Hypertension. 2003, 41: 378-381. 10.1161/01.HYP.0000049624.99844.3D.CrossRefPubMed
41.
go back to reference Stocker R, Keaney JF: Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004, 84: 1381-1478. 10.1152/physrev.00047.2003.CrossRefPubMed Stocker R, Keaney JF: Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004, 84: 1381-1478. 10.1152/physrev.00047.2003.CrossRefPubMed
42.
go back to reference Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K: Endothelial function and oxidative stress in renovascular hypertension. N Eng J Med. 2002, 25: 1954-1962. 10.1056/NEJMoa013591.CrossRef Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K: Endothelial function and oxidative stress in renovascular hypertension. N Eng J Med. 2002, 25: 1954-1962. 10.1056/NEJMoa013591.CrossRef
43.
go back to reference Lavi S, Yang EH, Prasad A, Mathemw V, Barness GW, Rihal CS, Lerman LO, Lerman A: The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008, 51: 127-133. 10.1161/HYPERTENSIONAHA.107.099986.CrossRefPubMed Lavi S, Yang EH, Prasad A, Mathemw V, Barness GW, Rihal CS, Lerman LO, Lerman A: The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008, 51: 127-133. 10.1161/HYPERTENSIONAHA.107.099986.CrossRefPubMed
44.
go back to reference Cheung YF, Ho MH, Tam SC, Yung TC: Increased high sensitivity C-reactive protein concentration and incrased areterial stifnfness in children with a history of Kawasaki disease. Heart. 2004, 90: 1281-1285. 10.1136/hrt.2003.018507.CrossRefPubMedPubMedCentral Cheung YF, Ho MH, Tam SC, Yung TC: Increased high sensitivity C-reactive protein concentration and incrased areterial stifnfness in children with a history of Kawasaki disease. Heart. 2004, 90: 1281-1285. 10.1136/hrt.2003.018507.CrossRefPubMedPubMedCentral
45.
go back to reference Mitani Y, Sawada H, Hayakawa H, Aoki A, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y: Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation. 2005, 111: 38-43. 10.1161/01.CIR.0000151311.38708.29.CrossRefPubMed Mitani Y, Sawada H, Hayakawa H, Aoki A, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y: Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation. 2005, 111: 38-43. 10.1161/01.CIR.0000151311.38708.29.CrossRefPubMed
46.
go back to reference Venugopal SK, Devaraj S, Jialal I: C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003, 108: 1676-1678. 10.1161/01.CIR.0000094736.10595.A1.CrossRefPubMed Venugopal SK, Devaraj S, Jialal I: C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003, 108: 1676-1678. 10.1161/01.CIR.0000094736.10595.A1.CrossRefPubMed
47.
go back to reference Singh U, Jialal I: Oxidative stress and atherosclerosis. Pathophysiology. 2006, 13: 129-142. 10.1016/j.pathophys.2006.05.002.CrossRefPubMed Singh U, Jialal I: Oxidative stress and atherosclerosis. Pathophysiology. 2006, 13: 129-142. 10.1016/j.pathophys.2006.05.002.CrossRefPubMed
48.
go back to reference Minuz P, Fava C, Cominacini L: Oxidative stress, antioxidantsm, and vascular damage. Br J Clin Pharmacol. 2006, 61: 774-777. 10.1111/j.1365-2125.2006.02681.x.CrossRefPubMedPubMedCentral Minuz P, Fava C, Cominacini L: Oxidative stress, antioxidantsm, and vascular damage. Br J Clin Pharmacol. 2006, 61: 774-777. 10.1111/j.1365-2125.2006.02681.x.CrossRefPubMedPubMedCentral
49.
go back to reference Yong X, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA. 1997, 94: 6954-6958. 10.1073/pnas.94.13.6954.CrossRef Yong X, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA. 1997, 94: 6954-6958. 10.1073/pnas.94.13.6954.CrossRef
50.
go back to reference Cheung YF, Karmin O, Tam SC, Siow YL: Induction of MCP1, CCR2 and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr Res. 2005, 58: 1306-1310. 10.1203/01.pdr.0000183360.79872.1c.CrossRefPubMed Cheung YF, Karmin O, Tam SC, Siow YL: Induction of MCP1, CCR2 and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr Res. 2005, 58: 1306-1310. 10.1203/01.pdr.0000183360.79872.1c.CrossRefPubMed
51.
go back to reference Kuhlencordt PJ, Chen J, Huang PL: Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation. 2001, 103: 3099-3104.CrossRefPubMed Kuhlencordt PJ, Chen J, Huang PL: Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation. 2001, 103: 3099-3104.CrossRefPubMed
52.
go back to reference Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, Cordi A, Serkiz B, Fabiani JN, Verbeuren TJ: Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation. 2000, 102: 1033-1038.CrossRefPubMed Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, Cordi A, Serkiz B, Fabiani JN, Verbeuren TJ: Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation. 2000, 102: 1033-1038.CrossRefPubMed
53.
go back to reference Jialal I, Devaraj S: Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation. 2003, 107: 926-928. 10.1161/01.CIR.0000048966.26216.4C.CrossRefPubMed Jialal I, Devaraj S: Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation. 2003, 107: 926-928. 10.1161/01.CIR.0000048966.26216.4C.CrossRefPubMed
54.
go back to reference Patterson C, Madamanchi NR, Runge MS: The oxidative paradox: another piece in the puzzle. Circ Res. 2000, 87: 1074-1076.CrossRefPubMed Patterson C, Madamanchi NR, Runge MS: The oxidative paradox: another piece in the puzzle. Circ Res. 2000, 87: 1074-1076.CrossRefPubMed
55.
go back to reference Wu R, Laplante M-A, de Champlain J: Prevention of angiotensin II induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens. 2004, 22: 793-802. 10.1097/00004872-200404000-00023.CrossRefPubMed Wu R, Laplante M-A, de Champlain J: Prevention of angiotensin II induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens. 2004, 22: 793-802. 10.1097/00004872-200404000-00023.CrossRefPubMed
Metadata
Title
Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness
Authors
Yiu-fai Cheung
Karmin O
Connie WH Woo
Stephanie Armstrong
Yaw L Siow
Pak-cheong Chow
Eddie WY Cheung
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2008
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-8-20

Other articles of this Issue 1/2008

BMC Pediatrics 1/2008 Go to the issue